Concord Medical Services Holdings Limited
CCM
$5.09
-$0.16-2.99%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -34.45% | -33.93% | -25.58% | -26.71% | -24.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.45% | -33.93% | -25.58% | -26.71% | -24.08% |
| Cost of Revenue | -30.34% | -29.78% | -21.73% | -22.91% | -26.58% |
| Gross Profit | 3.77% | 3.01% | -7.55% | -5.93% | 39.44% |
| SG&A Expenses | 42.04% | 43.17% | -14.44% | -15.74% | -4.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.08% | 0.71% | -19.15% | -20.37% | -18.67% |
| Operating Income | -34.83% | -35.90% | 10.60% | 11.95% | 12.32% |
| Income Before Tax | -3.61% | -4.43% | -39.66% | -37.54% | 44.24% |
| Income Tax Expenses | -666.29% | -672.93% | 64.16% | 64.70% | 98.14% |
| Earnings from Continuing Operations | -1.21% | -2.02% | -51.21% | -48.93% | 37.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 64.98% | 66.29% | 26.83% | 24.91% | -14.87% |
| Net Income | 33.96% | 33.43% | -83.20% | -80.43% | 45.76% |
| EBIT | -34.83% | -35.90% | 10.60% | 11.95% | 12.32% |
| EBITDA | -45.02% | -48.49% | 12.19% | 13.52% | 14.37% |
| EPS Basic | 33.96% | 33.43% | -83.19% | -80.42% | 45.76% |
| Normalized Basic EPS | 75.81% | 75.62% | -- | -- | -49.42% |
| EPS Diluted | 33.86% | 33.33% | -83.19% | -80.42% | 45.71% |
| Normalized Diluted EPS | 75.81% | 75.62% | -- | -- | -49.42% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |